213 related articles for article (PubMed ID: 15911313)
1. Synthesis and biological evaluation of aromatic enones related to curcumin.
Robinson TP; Hubbard RB; Ehlers TJ; Arbiser JL; Goldsmith DJ; Bowen JP
Bioorg Med Chem; 2005 Jun; 13(12):4007-13. PubMed ID: 15911313
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of novel curcumin analogs as anti-cancer and anti-angiogenesis agents.
Adams BK; Ferstl EM; Davis MC; Herold M; Kurtkaya S; Camalier RF; Hollingshead MG; Kaur G; Sausville EA; Rickles FR; Snyder JP; Liotta DC; Shoji M
Bioorg Med Chem; 2004 Jul; 12(14):3871-83. PubMed ID: 15210154
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of novel curcumin mimics with asymmetrical units and their anti-angiogenic activity.
Woo HB; Shin WS; Lee S; Ahn CM
Bioorg Med Chem Lett; 2005 Aug; 15(16):3782-6. PubMed ID: 15993583
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of curcumin analogues as potential thioredoxin reductase inhibitors.
Qiu X; Liu Z; Shao WY; Liu X; Jing DP; Yu YJ; An LK; Huang SL; Bu XZ; Huang ZS; Gu LQ
Bioorg Med Chem; 2008 Sep; 16(17):8035-41. PubMed ID: 18678491
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of 3-substituted-2-oxoindole analogues and their evaluation as kinase inhibitors, anticancer and antiangiogenic agents.
Abadi AH; Abou-Seri SM; Abdel-Rahman DE; Klein C; Lozach O; Meijer L
Eur J Med Chem; 2006 Mar; 41(3):296-305. PubMed ID: 16494969
[TBL] [Abstract][Full Text] [Related]
6. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
[TBL] [Abstract][Full Text] [Related]
7. Novel prodrugs of tegafur that display improved anticancer activity and antiangiogenic properties.
Engel D; Nudelman A; Tarasenko N; Levovich I; Makarovsky I; Sochotnikov S; Tarasenko I; Rephaeli A
J Med Chem; 2008 Jan; 51(2):314-23. PubMed ID: 18163551
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationship studies of curcumin analogues.
Fuchs JR; Pandit B; Bhasin D; Etter JP; Regan N; Abdelhamid D; Li C; Lin J; Li PK
Bioorg Med Chem Lett; 2009 Apr; 19(7):2065-9. PubMed ID: 19249204
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationship of C5-curcuminoids and synthesis of their molecular probes thereof.
Yamakoshi H; Ohori H; Kudo C; Sato A; Kanoh N; Ishioka C; Shibata H; Iwabuchi Y
Bioorg Med Chem; 2010 Feb; 18(3):1083-92. PubMed ID: 20060305
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and biological evaluation of angiogenesis inhibitors: aromatic enone and dienone analogues of curcumin.
Robinson TP; Ehlers T; Hubbard IV RB; Bai X; Arbiser JL; Goldsmith DJ; Bowen JP
Bioorg Med Chem Lett; 2003 Jan; 13(1):115-7. PubMed ID: 12467629
[TBL] [Abstract][Full Text] [Related]
11. Thrombospondin-1 mimetic peptide inhibitors of angiogenesis and tumor growth: design, synthesis, and optimization of pharmacokinetics and biological activities.
Haviv F; Bradley MF; Kalvin DM; Schneider AJ; Davidson DJ; Majest SM; McKay LM; Haskell CJ; Bell RL; Nguyen B; Marsh KC; Surber BW; Uchic JT; Ferrero J; Wang YC; Leal J; Record RD; Hodde J; Badylak SF; Lesniewski RR; Henkin J
J Med Chem; 2005 Apr; 48(8):2838-46. PubMed ID: 15828822
[TBL] [Abstract][Full Text] [Related]
12. 4-Aryl-1,2,3-triazole: a novel template for a reversible methionine aminopeptidase 2 inhibitor, optimized to inhibit angiogenesis in vivo.
Kallander LS; Lu Q; Chen W; Tomaszek T; Yang G; Tew D; Meek TD; Hofmann GA; Schulz-Pritchard CK; Smith WW; Janson CA; Ryan MD; Zhang GF; Johanson KO; Kirkpatrick RB; Ho TF; Fisher PW; Mattern MR; Johnson RK; Hansbury MJ; Winkler JD; Ward KW; Veber DF; Thompson SK
J Med Chem; 2005 Sep; 48(18):5644-7. PubMed ID: 16134930
[TBL] [Abstract][Full Text] [Related]
13. [Study on the effects of curcumin on angiogenesis].
Gao C; Ding Z; Liang B; Chen N; Cheng D
Zhong Yao Cai; 2003 Jul; 26(7):499-502. PubMed ID: 14650061
[TBL] [Abstract][Full Text] [Related]
14. Angiogenesis inhibitors identified by cell-based high-throughput screening: synthesis, structure-activity relationships and biological evaluation of 3-[(E)-styryl]benzamides that specifically inhibit endothelial cell proliferation.
Hada K; Suda A; Asoh K; Tsukuda T; Hasegawa M; Sato Y; Ogawa K; Kuramoto S; Aoki Y; Shimma N; Ishikawa T; Koyano H
Bioorg Med Chem; 2012 Feb; 20(4):1442-60. PubMed ID: 22269278
[TBL] [Abstract][Full Text] [Related]
15. Curcumin: the story so far.
Sharma RA; Gescher AJ; Steward WP
Eur J Cancer; 2005 Sep; 41(13):1955-68. PubMed ID: 16081279
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and discovery of 5-hydroxyaurone derivatives as growth inhibitors against HUVEC and some cancer cell lines.
Cheng H; Zhang L; Liu Y; Chen S; Cheng H; Lu X; Zheng Z; Zhou GC
Eur J Med Chem; 2010 Dec; 45(12):5950-7. PubMed ID: 20974505
[TBL] [Abstract][Full Text] [Related]
17. Naphthamides as novel and potent vascular endothelial growth factor receptor tyrosine kinase inhibitors: design, synthesis, and evaluation.
Harmange JC; Weiss MM; Germain J; Polverino AJ; Borg G; Bready J; Chen D; Choquette D; Coxon A; DeMelfi T; DiPietro L; Doerr N; Estrada J; Flynn J; Graceffa RF; Harriman SP; Kaufman S; La DS; Long A; Martin MW; Neervannan S; Patel VF; Potashman M; Regal K; Roveto PM; Schrag ML; Starnes C; Tasker A; Teffera Y; Wang L; White RD; Whittington DA; Zanon R
J Med Chem; 2008 Mar; 51(6):1649-67. PubMed ID: 18324761
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of BC-ring model of globostellatic acid X methyl ester, an anti-angiogenic substance from marine sponge.
Kotoku N; Tamada N; Hayashi A; Kobayashi M
Bioorg Med Chem Lett; 2008 Jun; 18(12):3532-5. PubMed ID: 18492609
[TBL] [Abstract][Full Text] [Related]
19. Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins.
Kunnumakkara AB; Anand P; Aggarwal BB
Cancer Lett; 2008 Oct; 269(2):199-225. PubMed ID: 18479807
[TBL] [Abstract][Full Text] [Related]
20. Novel 5-substituted, 2,4-diaminofuro[2,3-d]pyrimidines as multireceptor tyrosine kinase and dihydrofolate reductase inhibitors with antiangiogenic and antitumor activity.
Gangjee A; Zeng Y; Ihnat M; Warnke LA; Green DW; Kisliuk RL; Lin FT
Bioorg Med Chem; 2005 Sep; 13(18):5475-91. PubMed ID: 16039863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
